Pulmonary hypertension associated with chronic obstructive pulmonary disease

Area of Science:

• Pulmonology
• Cardiology
• Vascular Biology

Background:

• Pulmonary hypertension (PH) frequently complicates chronic obstructive pulmonary disease (COPD).
• While most patients experience mild to moderate PH, a subset develops severe, disproportionate PH.
• Endothelial dysfunction is increasingly recognized in the pathogenesis of PH in COPD, beyond chronic hypoxemia.

Purpose of the Study:

• To review the role of endothelial dysfunction in the pathogenesis of PH in COPD.
• To discuss the clinical recognition and diagnostic methods for PH in COPD patients.
• To explore current and emerging therapeutic strategies for PH associated with COPD.

Main Methods:

• Literature review focusing on the pathophysiology, diagnosis, and treatment of PH in COPD.
• Analysis of the role of pulmonary vascular remodeling and endothelial dysfunction.
• Evaluation of diagnostic tools including echocardiography and right heart catheterization.

Main Results:

• Pulmonary vascular remodeling, including intimal enlargement and medial hypertrophy, characterizes severe PH in COPD.
• Endothelial dysfunction contributes significantly to the pathogenesis of PH in COPD.
• Long-term oxygen therapy is the only established treatment to slow PH progression in moderate hypoxemia.

Conclusions:

• Severe PH in COPD is associated with significant pulmonary vascular remodeling and endothelial dysfunction.
• Accurate diagnosis relies on screening with echocardiography and confirmation with right heart catheterization.
• Investigational therapies targeting endothelial dysfunction may offer future management options for severe PH in COPD.